Inaktiver Wert

Andere Sprachen Golden Sun Capital Inc Toronto S.E.

Aktien

GSTh

CA38123A1093

GSTh

Schlusskurs Toronto S.E. Andere Börsenplätze
-	-

11.06.	Voyageur Pharmaceuticals Ltd. und Rain Cage Carbon Inc. kündigen Folgemaßnahmen zur ersten kommerziellen Herstellung von V@C60 Endohedral Fullerene an	CI
28.05.	Voyageur Pharmaceuticals Ltd sichert sich einen Vertriebsvertrag über 1,9 Millionen USD für SmoothXTM 2% Barium Contrast	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Voyageur Pharmaceuticals and Rain Cage Carbon Partner to Develop Advanced Radiology Contrast Agents	11.06.
Voyageur Pharmaceuticals Ltd. and Rain Cage Carbon Inc. Announce Follow Up on the First Commercial Creation of V@C60 Endohedral Fullerene	11.06.
Testing to Begin of Radiology Endohedral Fullerenes, a Milestone in Nanotechnology & Drug Development	11.06.
Voyageur Pharmaceuticals Secures $1.9 Million Sales Contract for Latin America	28.05.
Voyageur Pharmaceuticals Ltd Secures USD 1.9 Million Sales Contract for SmoothXTM 2% Barium Contrast	28.05.
Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium Contrast	28.05.
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended February 29, 2024	26.04.
Voyageur Pharmaceuticals Ltd Grants Deferred Share Units Compensation to Independent Directors	03.04.
Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options	26.03.
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended November 30, 2023	26.03.
Voyageur Pharmaceuticals Ltd. Announces A Significant Advancement in Its Partnership with Rain Cage Carbon Inc	13.03.
Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development	13.03.
Voyageur Pharmaceuticals Ltd. and Applied Pharmaceutical Innovation Sign Master Services Agreement	04.03.
Voyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug Advancement	04.03.
Voyageur Pharmaceuticals Ltd. Announces Closing of Private Placement	01.03.
Voyageur Pharmaceuticals Ltd. announced that it has received CAD 0.4885 million in funding	01.03.
Voyageur Pharmaceuticals Ltd. announced that it expects to receive CAD 0.8 million in funding	16.01.
Voyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to Directors	21.12.
Voyageur Pharmaceuticals Ltd and Rain Cage Carbon Inc, Announce Breakthrough in Imaging Technology with Vanadium Fullerene Molecule	21.12.
Voyageur Pharmaceuticals takes major step forward announcing international expansion	18.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Golden Sun Capital Inc Toronto S.E.

Aktien

GSTh

CA38123A1093

GSTh

Andere Sprachen

Filter